Skip to main content
Contact Us FAQ Feedback
Coat of Arms of the United Republic of Tanzania

United Republic of Tanzania

Ministry of Health

MPMED-SEZ Investor Portal

MPMED-SEZ - Mloganzila Pharmaceuticals and Medical Devices Special Economic Zone

Build where demand is structurally guaranteed

1,405 acres of investment-ready pharmaceutical and medical device infrastructure serving East and Southern Africa.

$1B+ TZ pharma market, today
4.6x Projected growth (15Y)
$491M MSD procurement / yr
1,405 Acres across two sites
780M+ EAC + SADC reach
60 days TMDA fast-track

Photo: Omari 2003 / Wikimedia Commons, CC BY-SA 4.0

Leadership

A national priority, led from the top

H.E. Dr. Samia Suluhu Hassan, President of the United Republic of Tanzania

H.E. Dr. Samia Suluhu Hassan

President of the United Republic of Tanzania

Hon. Mohamed O. Mchengerwa (MP), Minister for Health

Hon. Mohamed O. Mchengerwa (MP)

Minister for Health

“Once you invest, comply with WHO-PQ and GMP, and manufacture competitively in Tanzania, the Government will actively protect your market position.”
The case

Why Tanzania, Why Now

$1B+ Market Today

Tanzania's pharmaceutical market already exceeds one billion dollars a year.

$491M Guaranteed Offtake

MSD procures every year and prefers qualifying local manufacturers by 15%.

780M+ Regional Consumers

One plant reaches the combined EAC and SADC markets.

ML-3 TMDA Classification

A WHO Maturity Level 3 regulator with a 60-day fast-track for the zone.

1,405 Acres

Two investment-ready sites: Mloganzila (405 ac) and Bagamoyo (1,000 ac).

Dual mandate

One zone, two regulated manufacturing sectors.

Pharmaceuticals

  • Essential generics with MSD framework demand
  • API and excipients with zero EAC competition
  • Vaccines and biologics as a national priority
View Opportunity →

Medical Devices

  • Over 90% of devices and consumables imported today
  • Purpose-built 60-acre devices zone with cleanroom plots
  • Diagnostics and IVDs at roughly 99% import dependence
View Opportunity →
Opportunities

Convert browsing into shortlisting.

Tier 1

Essential Medicines Manufacturing

$15M – $80M

20–40% - import substitution opportunity

  • MSD framework contracts with 15% local price preference
  • WHO-PQ and GMP support through the TMDA 60-day fast-track
  • 20–40% import substitution headroom in national demand
View →
Tier 2

API & Excipients Manufacturing

$50M – $200M

Zero - EAC production capacity today

  • First-mover position: zero EAC API capacity exists today
  • Feedstock for Tier 1 formulation plants inside the same zone
  • Bagamoyo greenfield site available for USD 50M+ strategic projects
View →
Tier 3

Vaccines & Biologics

$80M – $300M

Zero - domestic human vaccine capacity

  • National priority: zero domestic human vaccine capacity
  • Green-lane approvals and government-to-government offtake channels
  • Regional pooled procurement access across EAC and SADC
View →
Tier 4

Small-Volume Parenterals

$5M – $40M

None - ampoules/vials manufactured in Tanzania

  • Purpose-zoned sterile sub-zone B3 (30 acres) ready for allocation
  • High-volume injectable demand in national procurement
  • Compact CAPEX with fast TMDA registration pathway
View →
Tier 5

Medical Devices & Consumables

$5M – $40M

>90% - currently imported

  • Over 90% import dependence across devices and consumables
  • 60-acre purpose-built Medical Devices zone (Zone A)
  • 15% MSD price preference on qualifying product lines
View →
Tier 6

Diagnostics & IVDs

$10M – $50M

~99% - currently imported

  • Approximately 99% of IVDs currently imported
  • Dedicated Diagnostics zone plus Lab Complex infrastructure
  • Same duty exemptions and fast-track as pharma manufacturers
View →
Two sites

Two Strategic Locations. One Vision.

Explore 1,405 acres of dedicated pharmaceutical and medical device manufacturing land across Tanzania's two strategic investment zones.

Mloganzila

Dar es Salaam Region

View Zone →
  • 405 acres
  • Diagnostics & medical devices
  • Near the Mloganzila national hospital
  • Finished pharmaceutical manufacturing
  • Brownfield-ready
  • Phase 1 plots open now

Bagamoyo

Coastal export corridor

View Zone →
  • 1,000 acres
  • API & biologics manufacturing
  • Export-oriented
  • Strategic investors (USD 50M+)
  • Deep-water port access
  • Masterplanning partnership
About

A Ministry of Health initiative

Build Manufacturing Base

Two purpose-built sites with pharma-grade utilities.

De-risk Investment

Incentives, fast-track regulation, and a single PIAT contact.

Anchor Demand

MSD's USD 491M annual procurement with local preference.

Open Regional Markets

EAC and SADC reach from one Tanzanian plant.

Learn More
Newsroom

Latest news

8 May 2026

Health Minister Lays Foundation Stone for Mloganzila Pharmaceutical Industrial Cluster

Health Minister Mohamed Mchengerwa has officially laid the foundation stone for the Mloganzila Pharmaceutical and Medical Devices Industrial Cluster.

Read more →
2 Mar 2026

Health Ministry Announces Strategic Shift to Scale Domestic Pharmaceutical Manufacturing

Health Minister Mohamed Mchengerwa has announced a high-level strategic shift to accelerate the construction of domestic pharmaceutical and health pr…

Read more →
9 Feb 2026

President Samia Directs Health Ministry to Fast-Track Pharmaceutical Sector Self-Reliance by 2030

President Samia Suluhu Hassan has issued an immediate executive mandate targeting the rapid expansion of local drug and medical equipment production.

Read more →
23 Dec 2025

Government Launches Pharmaceutical Investment Acceleration Task Force (PIAT) to Drive Industrial Growth

The Government of Tanzania has officially launched the Pharmaceutical Investment Acceleration Task Force (PIAT) to strengthen national health securit…

Read more →
View All News

Ready to establish your presence in East Africa?

PIAT responds to every expression of interest within five working days.